Sponsor or institution

Clinical trials and research at Olema Pharmaceuticals, Inc.

• 2Clinical trials
• 24Countries

All recruiting trials (2)

• Palazestrant plus ribociclib as first-line treatment for ER+/HER2- advanced breast cancer

  This trial will test whether using palazestrant instead of letrozole, both given with ribociclib, helps adults with ER+/HER2- advanced breast cancer who have not had prior systemic treatment for their advanced disease.

  Recruiting at 198 sites Phase 3 Olema Pharmaceuticals, Inc. · Hot Springs, Arkansas and 199 other locations · NCT07085767

• Testing OP-3136 for advanced solid tumors

  This study is testing a new drug called OP-3136 to see if it can safely help people with advanced solid tumors.

  Recruiting at 24 sites Phase 1 Olema Pharmaceuticals, Inc. · Gilbert, Arizona and 24 other locations · NCT06784193

Quick answers

How many clinical trials run by Olema Pharmaceuticals, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in Australia (2 trials), France (2 trials), Hong Kong (2 trials), Spain (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →